https://achrsignals.com/index.....php/light-activated-
OUTCOMES Between 2015-2017, 31 customers were enrolled. Two patients dropped out prior to any therapy. Median age had been 60 many years (range, 30-76) and 12 had been male. The most frequent tumor types were melanoma (59%) and non-small cellular lung disease (18%). No DLT's had been observed. The most common serious unfavorable event was grade 3 asthenia (6.9%, 2/29). The median intracranial response price was 46% (95%Cwe 24-68) and median OS had been 5.2 months (95%CI 4.5-9
Like
Comment
Share
